Matinas BioPharma (MTNB) Appoints Eric Ende to its Board of Directors
StreetInsider.com Matinas BioPharma Holdings, Inc. (NYSE MKT: MTNB) announced today the appointment of Eric J. Ende, M.B.A, M.D., to its Board of Directors, effective Monday, April 3, 2017. Dr. Ende is a life sciences executive with over 20 years of financial leadership ... and more » |
March 30, 2017 at 04:25PM
http://ift.tt/2oktUQO
from
http://ift.tt/2oktUQO
No comments:
Post a Comment